邁克生物(300463.SZ):擬延長向特定對象發行股票股東大會決議有效期及相關授權有效期
格隆匯8月1日丨邁克生物(300463.SZ)公佈,鑑於本次向特定對象發行股票的股東大會決議有效期和相關授權有效期即將到期,為確保本次向特定對象發行股票工作的順利推進,公司於2021年7月30日召開第四屆董事會第十九次會議,審議通過了《關於延長公司向特定對象發行股票股東大會決議有效期的議案》、《關於提請公司股東大會延長授權董事會全權辦理本次向特定對象發行股票相關事宜有效期的議案》,董事會提請股東大會將本次向特定對象發行股票的股東大會決議有效期、股東大會授權董事會全權辦理本次向特定對象發行股票相關事宜的有效期自原屆滿之日起延長至中國證監會出具的批覆有效期屆滿日。公司於同日召開第四屆監事會第十八次會議,審議通過了《關於延長公司向特定對象發行股票股東大會決議有效期的議案》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.